NextGen Jane Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $9M
Latest Deal Amount
  • Investors
  • 15

NextGen Jane General Information

Description

Developer of a reproductive health platform intended to offer information on women's reproductive health. The company's platform uses a patented tampon collection technology to transform the diverse molecular signals from the endometrium, cervix, fallopian tubes and ovaries shed during menstruation into digital diagnoses for in-depth sequencing analysis and disease detection, enabling women to send their menstrual samples and predict reproductive diseases in a hassle-free manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 1090 63rd Street
  • Unit 4
  • Oakland, CA 94608
  • United States
+1 (925) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NextGen Jane Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 29-Mar-2019 $9M 000.00 000.00 Completed Generating Revenue
2. Seed Round 09-Mar-2016 00.000 00.000 00.000 Completed Startup
1. Accelerator/Incubator 09-Dec-2015 Completed Startup
To view NextGen Jane’s complete valuation and funding history, request access »

NextGen Jane Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Seed 0,000,000 00.000000 00.00 00.00 00 00.00 00.00
To view NextGen Jane’s complete cap table history, request access »

NextGen Jane Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a reproductive health platform intended to offer information on women's reproductive health. The company's
Laboratory Services (Healthcare)
Oakland, CA
000.00
00.00 0000-00-00
00000000000 000.00

00000000

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehen
0000000000000
New York, NY
00 As of 0000
000.00
0000000000 0 000.00

00000000

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000000 0000000 0000000
San Diego, CA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NextGen Jane Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Celmatix Venture Capital-Backed New York, NY 00 000.00 0000000000 0 000.00
00000000 000000000 Venture Capital-Backed San Diego, CA 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Sunnyvale, CA 000 00000 00000000000 00000
0000000 Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000000 0000000 Venture Capital-Backed South San Francisco, CA 00 0000 00000000000 0000
To view NextGen Jane’s complete competitors history, request access »

NextGen Jane Executive Team (2)

Name Title Board Seat Contact Info
Ridhi Tariyal Co-Founder, Board Member & Chief Executive Officer
Stephen Gire Co-Founder, Board Member, Chief Scientific Officer & Chief Product Designer
To view NextGen Jane’s complete executive team members history, request access »

NextGen Jane Board Members (2)

Name Representing Role Since
Adam Sharkawy Ph.D Material Impact Fund Board Member 000 0000
Deborah Kilpatrick Ph.D Material Impact Fund Board Member 000 0000
To view NextGen Jane’s complete board members history, request access »

NextGen Jane Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Access Industries Corporation Minority 000 0000 000000 0
Anne Morriss Angel (individual) Minority 000 0000 000000 0
David Walt Angel (individual) Minority 000 0000 000000 0
Deborah Kilpatrick Angel (individual) Minority 000 0000 000000 0
Frances Frei Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »